BSF Enterprise Plc (LON:BSFA)
London · Delayed Price · Currency is GBP · Price in GBX 1.000
+0.125 (14.29%)
Mar 30, 2026, 11:16 AM GMT
BSF Enterprise Revenue
In the fiscal year ending September 30, 2025, BSF Enterprise had annual revenue of 52.84K GBP, down -8.61%. BSF Enterprise had revenue of 32.28K in the half year ending September 30, 2025, with 149.43% growth.
Revenue
52.84K
Revenue Growth
-8.61%
P/S Ratio
21.26
Revenue / Employee
3.77K
Employees
14
Market Cap
1.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 52.84K | -4.98K | -8.61% |
| Sep 30, 2024 | 57.82K | 44.88K | 346.77% |
| Sep 30, 2023 | 12.94K | - | - |
| Sep 30, 2022 | - | - | - |
| Sep 30, 2021 | - | - | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Futura Medical | 7.93M |
| IXICO | 6.53M |
| OptiBiotix Health | 1.15M |
| Oxford BioDynamics | 1.10M |
| Physiomics | 1.01M |
| ValiRx | 49.78K |
| CRISM Therapeutics | 25.00K |
| Thalia Therapeutics | 7.07K |
BSF Enterprise News
- 2 years ago - BSF Enterprise PLC Announces Participation in The ThinkEquity Conference - Newsfile Corp
- 2 years ago - BSF Enterprise PLC Provides City-MixTM Bio-Pharmaceutical Update - GlobeNewsWire